推荐产品
等级
certified reference material
pharmaceutical secondary standard
质量水平
Agency
traceable to USP 1012495
API类
beta-alanine
CofA
current certificate can be downloaded
技术
HPLC: suitable
gas chromatography (GC): suitable
mp
202 °C (dec.) (lit.)
应用
pharmaceutical (small molecule)
格式
neat
储存温度
2-30°C
SMILES字符串
NCCC(O)=O
InChI
1S/C3H7NO2/c4-2-1-3(5)6/h1-2,4H2,(H,5,6)
InChI key
UCMIRNVEIXFBKS-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
一般描述
用于质量控制的制药二级标准品，为制药实验室和制造商制备内部工作标准品提供了一种方便、高性价比的替代方案。β-丙氨酸是一种非蛋白质氨基酸，广泛存在于植物中，作为必需维生素泛酸盐的前体之一。它在微生物测定中表现出渗透保护剂的特性。它也是白花科植物中 β-丙氨酸甜菜碱的前体。
应用
这些二级标准品是合格的认证标准物质（CRM）。它们适用于多种分析应用，包括但不限于药物释放测试、药物的定性和定量分析方法开发、食品和饮料质量控制检测以及其他校准需求。
生化/生理作用
β丙氨酸是一种 β− 氨基酸，是泛酸的组分，是组氨酰基抗氧化剂二肽肌肽和鹅肌肽生物合成中的限速氨基酸。内源性 β-氨基酸，是甘氨酸受体的非选择性激动剂和G蛋白偶联孤儿受体TGR7（MrgD）的配体。 β-丙氨酸通量通过维持海洋生物、植入前小鼠胚胎和暴露于缺氧应激的哺乳动物细胞的渗透稳定性而发挥细胞保护作用。
分析说明
这些二级标准品可追溯至USP、EP（PhEur）和BP一级标准品。
其他说明
该认证标准物质（CRM）根据ISO 17034 和 ISO/IEC 17025进行生产和认证。有关此CRM使用的所有信息均可在检验报告上找到。
附注
想要查看本品的检验报告示例，请在下框中输入LRAC3952。这只是一个示例证书，可能与您收到的批次不符。
WGK
WGK 1
闪点(°F)
Not applicable
闪点(°C)
Not applicable
Physiology and Molecular Biology of Stress Tolerance in Plants (2006)
Julie Y Culbertson et al.
Nutrients, 2(1), 75-98 (2010-01-01)
Muscle carnosine has been reported to serve as a physiological buffer, possess antioxidant properties, influence enzyme regulation, and affect sarcoplasmic reticulum calcium regulation. Beta-alanine (β-ALA) is a non-essential amino acid. β-ALA supplementation (e.g., 2-6 grams/day) has been shown to increase
K E Tiedje et al.
Neurochemistry international, 57(3), 177-188 (2010-06-15)
This review discusses the role of beta-alanine as a neurotransmitter. Beta-alanine is structurally intermediate between alpha-amino acid (glycine, glutamate) and gamma-amino acid (GABA) neurotransmitters. In general, beta-alanine satisfies a number of the prerequisite classical criteria for being a neurotransmitter: beta-alanine
Partha Sardar et al.
The American journal of cardiology, 113(7), 1173-1177 (2014-02-12)
Dabigatran is a novel oral anticoagulant and may be useful during atrial fibrillation (AF) ablation for prevention of thromboembolic events. However, the benefits and adverse effects of periprocedural dabigatran therapy have not been thoroughly evaluated. A meta-analysis was performed to
Ajay Yadlapati et al.
The American journal of cardiology, 113(8), 1362-1363 (2014-03-01)
Direct-current cardioversion (DCCV) for persistent atrial fibrillation or atrial flutter (AF) carries a risk of thromboembolic events (TEs). Therapeutic anticoagulation with warfarin is recommended for 3 to 4 weeks before and 4 weeks after DCCV to reduce TE; however, the
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门